Tereza Sardinha, MD
Colon & Rectal Surgery · New Hyde Park, NYNPI 1548309610
Payments from drug & device makers
What this record shows
This record is dominated by education: $8,500 of the $11,230 with a category attached, or 75.7%. Intuitive Surgical accounts for 88.4% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $8,311, 4.1 times the $2,014 reported in 2019.
Across 48 payments — averaging $233.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- TEI Biosciences Inc$223
- Dilon Technologies, Inc.$221
- Boehringer Ingelheim$125
- Aurinia Pharma U.S., Inc.$125
- AstraZeneca$120
- plus $490 from 14 others
What the payments were for
- Travel & lodging$6145%
- Food & beverage$2,11719%
- Education$8,50076%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 19 | $9,926 |
| TEI Biosciences Inc | 3 | $223 |
| Dilon Technologies, Inc. | 5 | $221 |
| Boehringer Ingelheim | 1 | $125 |
| Aurinia Pharma U.S., Inc. | 1 | $125 |
| AstraZeneca | 1 | $120 |
| W. L. Gore & Associates, Inc. | 1 | $115 |
| Davol Inc. | 1 | $73 |
| Ferring Pharmaceuticals Inc. | 4 | $68 |
| Johnson & Johnson | 2 | $52 |
| Derma Sciences, Inc. | 1 | $24 |
| Smith+Nephew | 1 | $22 |
| Heron Therapeutics, Inc. | 1 | $21 |
| Convatec Inc. | 1 | $18 |
| Olympus America Inc. | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
| THD America, Inc. | 1 | $16 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| TELA Bio, Inc. | 1 | $15 |
| Axonics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$7,000
- Da Vinci Surgical System$2,646
- JARDIANCE$125
- LUPKYNIS$125
- LOKELMA$120
- BIO-A Tissue Reinforcement$115
- HemoBlast Bellows$108
- SURGIMEND$103
How this compares
$11,230 in reported general payments places this provider in the 85th percentile of 177 colon & rectal surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LoperamideLoperamide Hcl | 11 | $247 |
| Ciprofloxacin Hcl | 13 | $54 |
| Metronidazole | 13 | $51 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in New Hyde Park
- David RivadeneiraWoodbury$271K
- Jerald WishnerMount Kisco$246K
- Sanghyun KimNew York$154K
- Ziad KronfolWest Nyack$81K
- Lynn OconnorHuntington$63K
- Mehraneh JafariNew York$50K
- Jeffrey MilsomNew York$42K
- Stephen RauhRochester$37K
- Evelyn IrizarryBronx$26K
- David SchwartzbergNew York$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.